会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • RASAMSONIA GENE AND USE THEREOF
    • RASAMSONIA基因及其用途
    • WO2014202616A2
    • 2014-12-24
    • PCT/EP2014/062737
    • 2014-06-17
    • DSM IP ASSETS B.V.
    • WU, Liang
    • C07K14/37
    • C07K14/37
    • The invention relates to apolypeptide which comprises (a) an amino acid sequence set out in SEQ ID NO: 20501 to 32240; (b) an amino acid sequence encoded by the nucleic acid sequence of SEQ ID NO: 1 to 20500; (c) or a variant polypeptide, wherein the variant polypeptide (i) has at least 70% sequence identity with the sequence set out in SEQ ID NO: 20501 to 32240, or (ii) has an amino acid sequence that differs in, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 or 12 amino acids from the amino acid sequence of SEQ ID NO: 20501 to 32240. The invention also relates to methods for using the polypeptide in industrial processes. 1 Also included in the invention are cells transformed with a polynucleotide according to the invention suitable for producing these proteins.
    • 本发明涉及多肽,其包含(a)SEQ ID NO:20501至32240所示的氨基酸序列; (b)由SEQ ID NO:1至20500的核酸序列编码的氨基酸序列; (c)或变体多肽,其中所述变体多肽(i)与SEQ ID NO:20501至32240所示的序列具有至少70%的序列同一性,或(ii)具有不同于2的氨基酸序列 ,3,4,5,6,7,8,9,10,11或12个氨基酸。本发明还涉及在工业过程中使用该多肽的方法。 本发明还包括用适于生产这些蛋白质的根据本发明的多核苷酸转化的细胞。
    • 5. 发明申请
    • CELLS FOR ITACONIC ACID PRODUCTION
    • 用于生产酸的细胞
    • WO2015181312A2
    • 2015-12-03
    • PCT/EP2015/061884
    • 2015-05-28
    • DSM IP ASSETS B.V.
    • ZHAO, ZhengMEIJRINK, BernardHOEVEN, VAN DER, Robertus Antonius MijndertWU, LiangROUBOS, Johannes AndriesGELDER, VAN, Marina
    • C12N15/52C12P7/46C12P7/62
    • C12P7/62C12N15/52C12P7/46
    • The present invention relates to a recombinant cell which is capable of producing one or more of itaconic acid,4-methyl itaconate or 1-methyl itaconate, wherein the said recombinant microorganism has been modified in its genome such that it results in a deficiency in the production of a trans-aconitate methyltransferase. A recombinant yeast cell which is capable of producing itaconic acid and which over expresses: -a nucleic 1 acid encoding a polypeptide having cis-aconitate decarboxylase activity; and-one or more nucleic acids encoding polypeptides which separately or together catalyze a reaction towards acetyl CoA,wherein the said recombinant microorganism has been modified in its genome such that it results in a deficiency in the production of a trans- aconitate methyltransferase. These recombinant yeast cells may be used in processes for the production of itaconic acid, 4-methyl itaconate or 1-methyl itaconate.
    • 本发明涉及能够产生衣康酸,衣康酸4-甲酯或衣康酸1-甲酯中的一种或多种的重组细胞,其中所述重组微生物已经在其基因组中被修饰,从而导致其中的缺陷 产生反式乌头碱甲基转移酶。 能够产生衣康酸并且过表达的重组酵母细胞: - 编码具有顺 - 乌头酸脱羧酶活性的多肽的核酸1酸; 一个或多个编码多肽的核酸,其单独或一起催化向乙酰CoA的反应,其中所述重组微生物已经在其基因组中被修饰,从而导致转基因甲基转移酶的产生缺陷。 这些重组酵母细胞可用于生产衣康酸,衣康酸4-甲酯或衣康酸1-甲酯的方法。
    • 6. 发明申请
    • PROCESS FOR THE PREPARATION OF 1,4-BUTANEDIAMINE VIA N-ACYL OR N-GUANIDYL PROTECTED 1,4-BUTANEDIAMINE PRECURSORS
    • 通过N-乙酰基或N-胍基保护的1,4-丁二烯前体制备1,4-丁二胺的方法
    • WO2011009859A1
    • 2011-01-27
    • PCT/EP2010/060480
    • 2010-07-20
    • DSM IP ASSETS B.V.WU, LiangRAEMAKERS-FRANKEN, Petronella, Catharina
    • WU, LiangRAEMAKERS-FRANKEN, Petronella, Catharina
    • C12P13/00
    • C12P13/001
    • The present invention relates to a novel method for the preparation of 1,4-diaminobutane [DAB]. The method according to the present invention involves at least one biocatalytic step which comprises the biocatalytic production of at least one N-protected precursor of DAB. The present invention also relates to a method for the preparation of DAB involving at least one biocatalytic step, and comprising the steps of a) biocatalytically preparing an N-protected precursor of DAB yielding a - biocatalytic reaction mixture containing the N-protected precursor of DAB, b) recovering the N-protected precursor from the biocatalytic reaction mixture and c) converting the N-protected precursor into DAB. More in particular, the present invention relates to a method for the preparation of DAB, wherein the at least N-protected precursor of DAB is selected from the group consisting of N5-protected ornithine, N-protected DAB, and N-protected 4-aminobutyraldehyde.
    • 本发明涉及一种制备1,4-二氨基丁烷[DAB]的新方法。 根据本发明的方法涉及至少一种生物催化步骤,其包括至少一种N-保护的DAB前体的生物催化产生。 本发明还涉及一种用于制备涉及至少一个生物催化步骤的DAB的方法,并且包括以下步骤:a)生物催化制备D受体的N-保护的前体,得到含有N-保护的DAB前体的生物催化反应混合物 b)从生物催化反应混合物回收N-保护的前体,和c)将N-保护的前体转化成DAB。 更具体地说,本发明涉及一种制备DAB的方法,其中DAB的至少N-保护的前体选自N5保护的鸟氨酸,N-保护的DAB和N-保护的4- 氨基丁。